Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

about

Advances in pharmacotherapy for treating endometriosis.An overview of early drug development for endometriosis.Overview of elagolix for the treatment of endometriosis.Pharmacologic treatment of the ovarian endometrioma.

P2860

Q38633773-0D71FF94-8E5C-4C69-A533-A0817D8D1DCE Q38653393-24272F4F-E176-4518-9D9C-C114AAAC2228 Q38791644-4F14FB08-B98F-46EE-ACC9-017790763781 Q38822468-D8B940E4-8EC6-4D7D-8750-539AFBC7DB36

P2860

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

Item

http://www.wikidata.org/entity/Q57498856

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2013

@uk

name

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@en

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@nl

type

Item

label

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@en

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@nl

prefLabel

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@en

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@nl

P1476

Elagolix, an Oral GnRH Antagon ...... A Randomized Controlled Study

@en

P2093

Bruce Carr

http://www.w3.org/2001/XMLSchema#string

Chris O'Brien

http://www.w3.org/2001/XMLSchema#string

Joshua Burke

http://www.w3.org/2001/XMLSchema#string

Kristof Chwalisz

http://www.w3.org/2001/XMLSchema#string

Linda Giudice

http://www.w3.org/2001/XMLSchema#string

Mahesh Fuldeore

http://www.w3.org/2001/XMLSchema#string

Ping Jiang

http://www.w3.org/2001/XMLSchema#string

Roland Jimenez

http://www.w3.org/2001/XMLSchema#string

Steven Hass

http://www.w3.org/2001/XMLSchema#string

W Paul Dmowski

http://www.w3.org/2001/XMLSchema#string

P2860

Placebo interventions for all clinical conditions

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.

Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.

Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity

Progestogens for endometriosis: forward to the past.

ACOG Practice Bulletin No. 51. Chronic pelvic pain.

GnRH analogs: options for endometriosis-associated pain treatment.

P304

105-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5301/JE.5000157

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30320043

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis

P932

6166402

http://www.w3.org/2001/XMLSchema#string

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

about

P2860

P2860

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932